Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : VNV-026
| Cat. No. | VNV-026 |
| Description | Wild-type parainfluenza virus type 2 particles which are inactivated by β-Propiolactone treatment. This product is intended for research use only. |
| Storage | -80°C |
| Shipping | Dry ice |
A: The products are primarily used for research purposes, such as studying the virus's molecular characteristics, mechanisms of infection, or potential antiviral therapies. They can also be used in diagnostic assays to detect the presence of Parainfluenza Virus 2 in biological samples.
A: Creative Biogene employs several quality control measures to ensure the purity and stability of our Wild-Type Parainfluenza Virus 2 products. These measures include genetic sequencing,physicochemical characterization,sterility testing,endotoxin testing and stability studies.
A: PIVs are characterised by producing enveloped virions and containing single-stranded negative sense RNA. Non-infectious virions have also been reported to contain RNA with positive polarity. The structural gene sequence of PIVs is as follows: 3′-NP-P-M-F-HN-L-5′.
A: Symptoms of a PIV-2 infection include fever, cough, runny nose, sore throat, and breathing difficulties. In severe cases, it can lead to bronchiolitis or pneumonia, especially in infants and people with weakened immune systems.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
I am extremely satisfied with Wild-Type Parainfluenza Virus 2's viral titer. The titer was impressively high, ensuring a strong and effective product.
The virus was isolated and characterized with great precision, ensuring its identity and purity.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.